http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8700432-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de0f9ab36a3e65a9cc11284b7f0d4134 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate | 1986-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7bb4b04da25b760689ffc9a481a907 |
| publicationDate | 1987-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-8700432-A3 |
| titleOfInvention | Use of melatonin or related compounds for the treatment of psoriasis |
| abstract | The method relates to the making of compositions useful for curing psoriasis in living creatures, including humans. Said compositions contain an active indolamine derivative, most preferably melatonin. Certain preferred compositions for topical use consist of lotions, foams or sprays, while compositions for oral ingestion consist of tablets, caplets or capsules and similar items. Treatment is implemented by topical application with light massage only, or in combination with oral dosage which can be used alone or in combination with the topical treatment. |
| priorityDate | 1985-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.